Document is current

Article History

Received: 15 March 2023

Accepted: 15 June 2023

First Online: 5 September 2023

Competing interests

: The sponsors had no role in designing or conducting the study and no role in gathering or analysing the data or writing the manuscript. The manuscript and its contents have not been published previously and are not being considered for publications elsewhere in whole or in part in any language, including publicly accessible web sites or e-print servers. We disclose, that Dr. Lopez-Ayala has received research grants from the Swiss Heart Foundation (FF20079 and FF21103) and speaker’s honoraria from Quidel, paid to the institution, outside the submitted work. Dr. Nestelberger has received research support from the Swiss National Science Foundation (P400PM_191037/1), the Prof. Dr. Max Cloëtta Foundation, the Margarete und Walter Lichtenstein-Stiftung (3MS1038), and the University Hospital Basel as well as speaker honoraria/consulting honoraria from Siemens, Beckman Coulter, Bayer, Ortho Clinical Diagnostics and Orion Pharma, outside the submitted work. Dr. Koechlin received a research grant from the Swiss Heart Foundation, the University of Basel, the Swiss Academy of Medical Sciences and the Gottfried and Julia Bangerter-Rhyner Foundation, as well as the “Freiwillige Akademische Gesellschaft Basel” and speaker honoraria from Roche Diagnostics and Siemens, outside the submitted work. Dr. Karin Wildi has received research funding from the Gottfried und Julia Bangerter-Rhyner Foundation, the Prince Charles Hospital Foundation and the Wesley Medical Research Foundation. Additionally, she received a PhD scholarship and tuition fee waver from the University of Queensland, Brisbane, Australia, outside of the submitted work. Dr. Mueller has received research support from the Swiss National Science Foundation, the Swiss Heart Foundation, the KTI, the University Hospital Basel, the University of Basel; Abbott, Beckman Coulter, Biomerieux, Brahms, Idorsia, Novartis, Ortho Diagnostics, Quidel, Roche, Siemens, Singulex, Sphingotec, as well as speaker honoraria/consulting honoraria from Amgen, Astra Zeneca, Bayer, Boehringer Ingelheim, BMS, Idorsia, Novartis, Osler, Roche, and Sanofi. All other authors (A.Y-S., J.B., M.R.G., H.S., P.B., O.M., FJ.M-S., M.C., DI.K., D.G., D.K., K.R., A.B.) declare that they have no conflict of interest with this study. The hs-cTn assays investigated were donated by the manufacturers, who had no role in the design of the study, the analysis of the data, the preparation of the manuscript, or the decision to submit the manuscript for publication.